SG11202109566XA - Method for preparing influenza ha split vaccine - Google Patents

Method for preparing influenza ha split vaccine

Info

Publication number
SG11202109566XA
SG11202109566XA SG11202109566XA SG11202109566XA SG 11202109566X A SG11202109566X A SG 11202109566XA SG 11202109566X A SG11202109566X A SG 11202109566XA SG 11202109566X A SG11202109566X A SG 11202109566XA
Authority
SG
Singapore
Prior art keywords
split vaccine
preparing influenza
influenza
preparing
vaccine
Prior art date
Application number
Inventor
Yoshimasa Takahashi
Yu Adachi
Manabu Ato
Original Assignee
Japan As Represented By Director General Of Nat Institute Of Infectious Diseases
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan As Represented By Director General Of Nat Institute Of Infectious Diseases, Sumitomo Dainippon Pharma Co Ltd filed Critical Japan As Represented By Director General Of Nat Institute Of Infectious Diseases
Publication of SG11202109566XA publication Critical patent/SG11202109566XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11202109566X 2019-03-04 2020-03-03 Method for preparing influenza ha split vaccine SG11202109566XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019038662 2019-03-04
PCT/JP2020/008974 WO2020179797A1 (en) 2019-03-04 2020-03-03 Method for preparing influenza ha split vaccine

Publications (1)

Publication Number Publication Date
SG11202109566XA true SG11202109566XA (en) 2021-10-28

Family

ID=72337458

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109566X SG11202109566XA (en) 2019-03-04 2020-03-03 Method for preparing influenza ha split vaccine

Country Status (13)

Country Link
US (1) US20220152191A1 (en)
EP (1) EP3936147A4 (en)
JP (1) JPWO2020179797A1 (en)
KR (1) KR20210135261A (en)
CN (1) CN114096273A (en)
AU (1) AU2020233456A1 (en)
BR (1) BR112021017310A8 (en)
CA (1) CA3132578A1 (en)
EA (1) EA202192398A1 (en)
IL (1) IL285984A (en)
MX (1) MX2021010685A (en)
SG (1) SG11202109566XA (en)
WO (1) WO2020179797A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104302317B (en) * 2012-05-16 2016-07-06 Kj生物科学有限公司 Influenza vaccines that are novel and that improve
KR20140118682A (en) 2013-03-29 2014-10-08 (주)셀트리온 Composition comprising two or more influenza A viruses neutralizing binding molecules
JP7403733B2 (en) * 2017-09-04 2023-12-25 国立感染症研究所長 Method for manufacturing influenza HA split vaccine
WO2020022272A1 (en) * 2018-07-23 2020-01-30 公益財団法人ヒューマンサイエンス振興財団 Composition containing influenza vaccine

Also Published As

Publication number Publication date
CA3132578A1 (en) 2020-09-10
EP3936147A4 (en) 2022-09-28
JPWO2020179797A1 (en) 2020-09-10
AU2020233456A1 (en) 2021-10-07
EA202192398A1 (en) 2021-11-23
BR112021017310A8 (en) 2022-12-06
US20220152191A1 (en) 2022-05-19
EP3936147A1 (en) 2022-01-12
MX2021010685A (en) 2021-12-10
KR20210135261A (en) 2021-11-12
IL285984A (en) 2021-10-31
CN114096273A (en) 2022-02-25
BR112021017310A2 (en) 2021-11-16
WO2020179797A1 (en) 2020-09-10

Similar Documents

Publication Publication Date Title
IL281220A (en) Process for preparing vaccine compositions
EP3538146A4 (en) Influenza vaccine
GB2572275B (en) Method for preparing Foot-and-Mouth disease vaccine
EP3708567A4 (en) Method for preparing benzofuran derivative
IL283331A (en) Method for preparing n-phenylpyrazole-1-carboxamides
SG11201911164WA (en) Method for preparing intermediate of 4-methoxypyrrole derivative
HK1259146A1 (en) Methods and compositions for influenza vaccination
IL280703A (en) Method for preparing liposomes
IL309408A (en) Multivalent influenza vaccines
GB202010113D0 (en) Method for preparing miscible nano-pesticide suspension
GB201910794D0 (en) Vaccine
PL3429546T3 (en) Method for preparing a medical preparation
GB201714060D0 (en) Method for preparing itraconazole preparation
SG11202001937TA (en) Method for producing influenza ha split vaccine
EP3543236A4 (en) Method for preparing avibactam intermediate
EP3562498A4 (en) Influenza vaccines
EP3505525A4 (en) Method for preparing rubusoside
GB201820751D0 (en) Methods for preparing intermediates
EP3650536A4 (en) Method for preparing influenza working virus seed stock, method for preparing influenza vaccine using same seed stock, and virus seed stock prepared by same method
EP3162378A4 (en) Influenza vaccine nasal vaccination system
SG11202109566XA (en) Method for preparing influenza ha split vaccine
GB202004825D0 (en) Influenza vaccines
IL282108A (en) Preparation method for efinaconazole
EP3858380A4 (en) Inactivated whole-virus influenza vaccine and method for preparing same
ZA202005179B (en) Method for preparing phloroglucinol